{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:30:26Z","timestamp":1793831426760,"version":"4.6.1"},"reference-count":33,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,10,15]]},"DOI":"10.2169\/internalmedicine.4888-20","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T22:05:29Z","timestamp":1592863529000},"page":"2601-2609","source":"Crossref","is-referenced-by-count":4,"title":["An Overlapping Case of IgG4-related Disease and Klinefelter Syndrome with Lupus-like Serological and Neurological Features: A Case Report and Literature Review"],"prefix":"10.2169","volume":"59","author":[{"given":"Satoshi","family":"Takanashi","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironari","family":"Hanaoka","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Ota","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Groth KA, Skakkeb\u00e6k A, H\u00f8st C, Gravholt CH, Bojesen A. Clinical review: Klinefelter syndrome-a clinical update. J Clin Endocrinol Metab 98: 20-30, 2013."},{"key":"2","unstructured":"2. Nielsen J, Wohlert M. Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet 87: 81-83, 1991."},{"key":"3","unstructured":"3. Scofield RH, Bruner GR, Namjou B, et al. Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum 58: 2511-2517, 2008."},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Seminog OO, Seminog AB, Yeates D, Goldacre MJ. Associations between Klinefelter's syndrome and autoimmune diseases: English national record linkage studies. Autoimmunity 48: 125-128, 2015.","DOI":"10.3109\/08916934.2014.968918"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tsokos GC. Systemic lupus erythematosus. N Engl J Med 365: 2110-2121, 2011.","DOI":"10.1056\/NEJMra1100359"},{"key":"6","unstructured":"6. Bojesen A, Juul S, Birkebaek NH, Gravholt CH. Morbidity in Klinefelter syndrome: a Danish register study based on hospital discharge diagnoses. J Clin Endocrinol Metab 91: 1254-1260, 2006."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Dillon S, Aggarwal R, Harding JW, et al. Klinefelter's syndrome (47,XXY) among men with systemic lupus erythematosus. Acta Paediatr 100: 819-823, 2011.","DOI":"10.1111\/j.1651-2227.2011.02185.x"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet 385: 1460-1471, 2015.","DOI":"10.1016\/S0140-6736(14)60720-0"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Kobayashi S, Yoshida M, Kitahara T, et al. Autoimmune pancreatitis as the initial presentation of systemic lupus erythematosus. Lupus 16: 133-136, 2007.","DOI":"10.1177\/0961203306073137"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yamamoto M, Aochi S, Suzuki C, et al. A case with good response to belimumab for lupus nephritis complicated by IgG4-related disease. Lupus 28: 786-789, 2019.","DOI":"10.1177\/0961203319840430"},{"key":"11","unstructured":"11. Naramala S, Biswas S, Adapa S, Gayam V, Konala VM. An overlapping case of IgG4-related disease and systemic lupus erythematosus. J Investig Med High Impact Case Rep. Forthcoming."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Zaarour M, Weerasinghe C, Eter A, El-Sayegh S, El-Charabaty E. An overlapping case of lupus nephritis and IgG4-related kidney disease. J Clin Med Res 7: 575-581, 2015.","DOI":"10.14740\/jocmr2189w"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nakashima Y, Nakamura H, Horai Y, et al. Comorbid case of IgG4-related disease and primary Sj\u00f6gren's syndrome. Mod Rheumatol 25: 462-467, 2015.","DOI":"10.3109\/14397595.2013.843750"},{"key":"14","unstructured":"14. Huang X, Lu B, Li M, Fan Y, Zhang L. IgG4-related retroperitoneal fibrosis overlapping with primary biliary cirrhosis and primary Sj\u00f6gren's syndrome: a case report. Medicine (Baltimore) 97: e11303, 2018."},{"key":"15","unstructured":"15. Danlos FX, Rossi GM, Blockmans D, et al. Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome. Autoimmun Rev 16: 1036-1043, 2017."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Nagayama Y, Takayasu M, Wakabayashi A, et al. New onset of immunoglobulin G4-related disease in a patient with relapsing polychondritis. Mod Rheumatol 27: 898-900, 2017.","DOI":"10.3109\/14397595.2015.1040610"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Schmitz-H\u00fcbsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 66: 1717-1720, 2006.","DOI":"10.1212\/01.wnl.0000219042.60538.92"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 22: 21-30, 2012.","DOI":"10.3109\/s10165-011-0571-z"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725, 1997.","DOI":"10.1002\/art.1780400928"},{"key":"20","unstructured":"20. Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis 78: 1151-1159, 2019."},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434: 400-404, 2005.","DOI":"10.1038\/nature03479"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sarmiento L, Svensson J, Barchetta I, Giwercman A, Cilio CM. Copy number of the X-linked genes TLR7 and CD40L influences innate and adaptive immune responses. Scand J Immunol 90: e12776, 2019.","DOI":"10.1111\/sji.12776"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Moser KL, Kelly JA, Lessard CJ, Harley JB. Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun 10: 373-379, 2009.","DOI":"10.1038\/gene.2009.39"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Graham RR, Ortmann WA, Langefeld CD, et al. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet 71: 543-553, 2002.","DOI":"10.1086\/342290"},{"key":"25","unstructured":"25. Souyris M, Cenac C, Azar P, et al. TLR7 escapes X chromosome inactivation in immune cells. Sci Immunol. Forthcoming."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Ishiguro N, Moriyama M, Furusho K, et al. Activated M2 macrophages contribute to the pathogenesis of IgG4-related disease via toll-like receptor 7\/interleukin-33 signaling. Arthritis Rheumatol 72: 166-178, 2020.","DOI":"10.1002\/art.41052"},{"key":"27","unstructured":"27. Terao C, Ota M, Iwasaki T, et al. IgG4-related disease in the Japanese population: a genome-wide association study. Lancet Rheumatol 1: e14-e22, 2019."},{"key":"28","unstructured":"28. Kyogoku C, Dijstelbloem HM, Tsuchiya N, et al. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis Rheum 46: 1242-1254, 2002."},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Chu ZT, Tsuchiya N, Kyogoku C, et al. Association of Fcgamma receptor IIb polymorphism with susceptibility to systemic lupus erythematosus in Chinese: a common susceptibility gene in the Asian populations. Tissue Antigens 63: 21-27, 2004.","DOI":"10.1111\/j.1399-0039.2004.00142.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Schonbeck U, Libby P. The CD40\/CD154 receptor\/ligand dyad. Cell Mol Life Sci 58: 4-43, 2001.","DOI":"10.1007\/PL00000776"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Murphy G, Isenberg DA. New therapies for systemic lupus erythematosus - past imperfect, future tense. Nat Rev Rheumatol 15: 403-412, 2019.","DOI":"10.1038\/s41584-019-0235-5"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Fava A, Petri M; Systemic lupus erythematosus. Diagnosis and clinical management. J Autoimmun 96: 1-13, 2019.","DOI":"10.1016\/j.jaut.2018.11.001"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Muraki T, Hamano H, Ochi Y, et al. Autoimmune pancreatitis and complement activation system. Pancreas 32: 16-21, 2006.","DOI":"10.1097\/01.mpa.0000188308.75043.e4"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/20\/59_4888-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T20:59:34Z","timestamp":1667077174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/20\/59_4888-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":33,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4888-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,15]]}}}